NICE issues draft guidance on dependence-forming medicines
The National Institute for Health and Care Excellence (NICE) has issued a new draft guideline on shared decision-making which looks at safe prescribing and...
CHASE updates its services and increases its divisions
CHASE, the UK’s largest independent provider of contract customer-facing teams, has carried out a programme of industry and NHS market research, to better understand...
Ground-breaking AI test could transform breast cancer diagnosis and treatment
Panakeia’s PANProfiler Breast assay - the world’s first AI software that can predict biomarker status from digitally imaged routine pathology samples - has received...
NHS Confederation calls for more measures to avoid a winter crisis
The NHS Confederation is calling for a ‘Plan B plus’ in a plea for the government to introduce measures, such as mandatory face coverings...
Star OUTiCO achieves Platinum Investors In People accreditation
Star OUTiCO, a market-leading provider of outsourced digitally enabled commercial services to the pharmaceutical industry, and part of the global Uniphar Group, has announced...
NICE recommends Ofev for the treatment of PF-ILD
The National Institute for Health and Care Excellence (NICE) has recommended Ofev® (nintedanib) for use in England and Wales for the treatment of adult patients...
NICE recommends new treatment for asthma in the UK
The National Institute for Health and Care Excellence (NICE) has issued a Final Appraisal Determination (FAD) recommending Dupixent® (dupilumab), as an add-on maintenance treatment...
New study to explore if talazoparib could treat metastatic breast cancer
A new study funded by Breast Cancer Now will explore if the drug talazoparib (Talzenna) could be used to treat people with incurable secondary...
£250m winter access fund for GPs to boost face to face appointments
The NHS has published a blueprint for improving access to GP appointments for patients alongside supporting GPs and their teams. Surgeries will be provided with additional funding...
Positive SMC decision for first long-acting injectable HIV treatment
ViiV Healthcare has announced that the Scottish Medicines Consortium (SMC) has accepted Vocabria▼ (cabotegravir long-acting injection) in combination with Rekambys▼ (rilpivirine long-acting injection) for...
Latest articles
NICE recommends Tagrisso for patients with early-stage lung cancer
Following a positive final recommendation from the National Institute for Health and Care Excellence (NICE), AstraZeneca’s Tagrisso (osimertinib) is now available as an adjuvant...
JCVI responds to Omicron variant and updates its guidance
The Joint Committee on Vaccination and Immunisation (JCVI) has responded to the emergence of the Omicron variant and updated its guidance, with immediate effect. A...
EC grants marketing authorisation for breast cancer treatment Trodelvy
The European Commission (EC) has granted marketing authorization for Gilead Sciences’ Trodelvy® (sacituzumab govitecan), as a monotherapy indicated for the treatment of adult patients with...
Popular articles
New Normal, New Thinking: Life Post COVID-19
New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
NICE recommends Tagrisso for patients with early-stage lung cancer
Following a positive final recommendation from the National Institute for Health and Care Excellence (NICE), AstraZeneca’s Tagrisso (osimertinib) is now available as an adjuvant...
A CLASS DIVIDED – A LIFE CHANGING EXPERIMENT
What can your team learn about positive thinking from a schoolteacher in the 1970s and a world heavy weight champion? Ama Verdi-Ashton explains. It...
JCVI responds to Omicron variant and updates its guidance
The Joint Committee on Vaccination and Immunisation (JCVI) has responded to the emergence of the Omicron variant and updated its guidance, with immediate effect. A...
Understanding the role of the MSL
Helen Kane surveyed more than 200 medical science liaisons (MSLs) to understand more about their current in-role reality. She gave Pf Magazine exclusive access...